Acutus Medical, Inc. Stock

Equities

AFIB

US0051111096

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 04:30:00 2024-04-18 pm EDT 5-day change 1st Jan Change
0.1745 USD +6.53% Intraday chart for Acutus Medical, Inc. -1.25% -13.57%
Sales 2022 16.36M Sales 2023 7.16M Capitalization 5.92M
Net income 2022 -39M Net income 2023 -81M EV / Sales 2022 0.07 x
Net cash position 2022 31.59M Net Debt 2023 16.08M EV / Sales 2023 3.07 x
P/E ratio 2022
-0.82 x
P/E ratio 2023
-0.07 x
Employees 232
Yield 2022 *
-
Yield 2023
-
Free-Float 96.39%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.53%
1 week-1.25%
Current month-7.18%
1 month-33.40%
3 months+2.71%
6 months-70.92%
Current year-13.57%
More quotes
1 week
0.16
Extreme 0.163
0.19
1 month
0.16
Extreme 0.16
0.22
Current year
0.16
Extreme 0.16
0.43
1 year
0.16
Extreme 0.16
1.09
3 years
0.16
Extreme 0.16
18.00
5 years
0.16
Extreme 0.16
38.99
10 years
0.16
Extreme 0.16
38.99
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 21-06-30
Chief Tech/Sci/R&D Officer - 10-12-31
Chief Operating Officer 62 19-09-30
Members of the board TitleAgeSince
Director/Board Member 48 16-02-29
Director/Board Member 68 21-03-16
Director/Board Member 57 21-08-09
More insiders
Date Price Change Volume
24-04-18 0.1745 +6.53% 732,616
24-04-17 0.1638 -0.30% 62,794
24-04-16 0.1643 -3.58% 99,386
24-04-15 0.1704 -2.68% 213,512
24-04-12 0.1751 -0.91% 298,106

Delayed Quote Nasdaq, April 18, 2024 at 04:30 pm EDT

More quotes
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.
More about the company